Method for determining high-mannose glycans
AssigneeGenovis AB
InventorsFredrik OLSSON, Stephen Georg BJOK, Maria NORDGREN, Sarah FREDRIKSSON
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for analysing molecules comprising immunoglobulin Fc regions for the presence or absence of high-mannose glycans, and to for carrying out such methods.
Claims20
A method for determining the presence or absence of high-mannose glycans attached to a molecule comprising an immunoglobulin Fc region, the method comprising:
- (a) contacting a sample of said molecule with an endoglycosidase polypeptide capable of cleaving high-mannose glycans to form a mixture;
- and
- (b) analysing the resulting mixture for the presence or absence of high-mannose glycans and/or Fc regions containing high-mannose glycans;
- and optionally
- (c) quantifying a proportion of molecules in the sample which contain high-mannose glycans by calculating a quantity of high-mannose glycans in the mixture relative to a total quantity of glycans in the mixture.
A kit comprising a polypeptide comprising the sequence of SEQ ID NO:
- 1, or a variant thereof, and optionally
- (a) means for detecting high-mannose glycans and/or high-mannose containing IgG molecules;
- and/or (b) instructions to detect high-mannose glycans and/or high-mannose containing IgG molecules.
A method for determining the presence or absence of high-mannose glycans attached to a molecule comprising an immunoglobulin Fc region, the method comprising:
- (a) contacting a sample of a first batch of said molecule with an endoglycosidase polypeptide capable of cleaving high-mannose glycans;
- (b) analysing the sample of the first batch for the presence, absence, or quantity of high-mannose glycans and/or Fc regions containing high-mannose glycans;
- (c) contacting a sample of a second batch of said molecule with an endoglycosidase polypeptide capable of cleaving high-mannose glycans;
- (d) analysing a the sample of the second batch for the presence, absence, or quantity of high-mannose glycans and/or Fc regions containing high-mannose glycans;
- and
- (e) comparing a result obtained from analyzing the sample of the first batch of said molecule to a result obtained from analyzing the sample of the second batch of said molecule.
Dependencies are inferred from the claim text.